Form 4: Ollie's CIO Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Ollie's Bargain Outlet Holdings' SVP, CIO Larry Kraus exercised stock options and subsequently sold the acquired shares, reducing his direct common stock holdings to 3,679 shares.

Summary

  • Larry Kraus, SVP, CIO of Ollie's Bargain Outlet Holdings, Inc. (OLLI), executed a series of transactions on October 6, 2025.
  • These transactions involved the exercise of employee stock options and the subsequent sale of the common stock acquired.
  • A total of 3,159 shares were acquired through option exercises (2,559 shares at $43.21, 500 shares at $57.98, and 100 shares at $86.03).
  • A total of 3,159 shares were disposed of through sales (2,559 shares at $131.55, 500 shares at a weighted average price of $130.51-$131.44, and 100 shares at a weighted average price of $131.27-$131.50).
  • All transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on July 7, 2025.
  • Following these transactions, Larry Kraus directly beneficially owns 3,679 shares of Common Stock.
  • He also retains beneficial ownership of 2,559 employee stock options with an exercise price of $43.21, 6,366 options with an exercise price of $57.98, and 4,534 options with an exercise price of $86.03.

Sentiment

Score: 6

Explanation: The filing reports a routine, pre-planned insider transaction where an executive exercised options and sold shares for a profit. While it involves insider selling, the pre-planned nature under Rule 10b5-1 mitigates negative sentiment, and the significant profit realized reflects positively on the company's stock performance.

Positives

  • The executive realized significant gains by exercising options at lower prices and selling shares at substantially higher market prices, indicating personal financial success.
  • The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a structured approach to managing equity holdings and mitigates concerns about opportunistic insider trading.
  • The company's stock price at the time of sale (around $131) is significantly higher than the option exercise prices ($43.21, $57.98, $86.03), reflecting strong stock performance.

Negatives

  • The sale of shares by a Senior Vice President and Chief Information Officer could be perceived as a reduction in direct equity exposure, although it is part of a pre-planned strategy.
  • The reduction in direct common stock holdings to 3,679 shares, while still retaining options, represents a decrease in immediate skin in the game.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports a routine insider transaction under a pre-arranged trading plan and does not provide information relevant to broader industry trends or competitive analysis.

Comparison to Industry Standards

  • This filing details a standard executive stock option exercise and sale under a Rule 10b5-1 plan, which is a common practice for executives to manage their equity compensation and personal finances. There are no specific comparable companies, projects, or results mentioned in this filing to assess against global benchmarks.

Stakeholder Impact

  • Shareholders: May note the executive's reduction in direct share ownership, but the pre-planned nature of the sale under Rule 10b5-1 typically lessens concerns about opportunistic selling. The executive still retains a significant number of options.
  • Employees: No direct impact mentioned.
  • Customers/Suppliers/Creditors: No direct impact mentioned.

Next Steps

  • The next installment of 1,717 options from the March 23, 2023 grant will vest on March 23, 2026.
  • The next installment of 2,559 options from the March 25, 2022 grant will vest on March 25, 2026.
  • The final installment of 1,716 options from the March 23, 2023 grant will vest on March 23, 2027.

Key Dates

DateDescription
2021-03-22Grant date for 4,634 options with an exercise price of $86.03, vesting in 25% installments. Options fully vested on March 22, 2025.
2022-03-25Grant date for 10,236 options with an exercise price of $43.21, vesting in 25% installments. First installment vested.
2023-03-23Grant date for 6,866 options with an exercise price of $57.98, vesting in 25% installments. First installment vested.
2023-03-25Second installment of 2,559 options vested from the March 25, 2022 grant.
2024-03-23Second installment of 1,717 options vested from the March 23, 2023 grant.
2024-03-25Third installment of 2,559 options vested from the March 25, 2022 grant.
2025-03-22All 4,634 options from the March 22, 2021 grant fully vested.
2025-03-23Third installment of 1,716 options vested from the March 23, 2023 grant.
2025-03-25Fourth installment of 2,559 options vested from the March 25, 2022 grant.
2025-07-07Date Rule 10b5-1 trading plan was adopted.
2025-10-06Date of reported option exercises and stock sales.
2025-10-08Date the Form 4 was signed by Attorney-In-Fact.
2026-03-23Fourth installment of 1,717 options will vest from the March 23, 2023 grant.
2026-03-25Fourth installment of 2,559 options will vest from the March 25, 2022 grant.
2027-03-23Fifth installment of 1,716 options will vest from the March 23, 2023 grant.
2031-03-22Expiration date for employee stock options with an exercise price of $86.03.
2032-03-25Expiration date for employee stock options with an exercise price of $43.21.
2033-03-23Expiration date for employee stock options with an exercise price of $57.98.

Recommendation

hold

This Form 4 filing details a routine, pre-planned insider transaction by a Senior Vice President and Chief Information Officer, involving the exercise of stock options and subsequent sale of shares. While it represents a reduction in direct share ownership, the transaction was executed under a Rule 10b5-1 plan, which is a common and transparent method for executives to manage their equity compensation. There is no new fundamental information about the company's operations, financial health, or strategic direction that would warrant a change in investment recommendation. The executive's profit-taking reflects past stock performance rather than a signal about future prospects. Therefore, a 'hold' recommendation is appropriate as this filing does not provide a basis for a 'buy' or 'sell' decision based on new company-specific insights.

Keywords

OLLI, Ollie's Bargain Outlet, Insider Trading, Form 4, Stock Options, Executive Compensation, Larry Kraus, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.